Avoro Capital Advisors LLC
Q1 2022 13F-HR Holdings
Net value change ($000)
-398,208
(-6.8%)
New positions
4
Sold out positions
1
Turnover %
6.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Seagen Inc. | 189,426 | NEW |
| XBI | 156,576 | 133.2% |
| APLS | 75,648 | 18.7% |
| ARGX | 57,781 | 17.1% |
| KRYS | 33,647 | 101.3% |
| BCRX | 30,488 | NEW |
| ALNY | 29,978 | 16.4% |
| KURA | 21,184 | 37.8% |
| MDGL | 19,066 | 15.8% |
| RARE | 16,703 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Horizon Therapeutics Public Ltd Co | -317,764 | -31.7% |
| Mirati Therapeutics, Inc. | -306,630 | -41.2% |
| ARENA PHARMACEUTICALS INC | -114,781 | -100.0% |
| UTHR | -112,191 | -17.1% |
| SRPT | -36,500 | -13.0% |
| GLUE | -21,193 | -31.3% |
| FOLD | -19,540 | -9.1% |
| Mersana Therapeutics, Inc. | -15,164 | -35.9% |
| IOVA | -13,675 | -8.3% |
| BMRN | -13,381 | -5.4% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|